StonvexLoading…
StonvexStonvexStonvexCore line items from SSP's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $516.87M | $2.15B | $1.59B | $1.06B |
Operating Income | $24.77M | $183.99M | $141.70M | $104.08M |
Net Income | $-1.79M | $-100.88M | $-72.38M | $-39.42M |
EPS (Diluted) | $-0.20 | $-1.87 | $-1.36 | $-0.81 |
Total Assets | $4.92B | $5.01B | $5.09B | $5.09B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $83.73M | $27.92M | $54.66M | $31.66M |
Free Cash Flow OCF − CapEx | $350.00K | $6.52M | $-24.72M | $-31.10M |
Shares Outstanding | 89.77M | 88.02M | 87.77M | 87.42M |